Carcinoma of the penis overview

Revision as of 09:09, 3 April 2019 by Swathi Venkatesan (talk | contribs) (→‎History and Symptoms)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Carcinoma of the penis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoma of the Penis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoma of the penis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoma of the penis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoma of the penis overview

CDC on Carcinoma of the penis overview

Carcinoma of the penis overview in the news

Blogs on Carcinoma of the penis overview

Directions to Hospitals Treating Carcinoma of the penis

Risk calculators and risk factors for Carcinoma of the penis overview

Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Swathi Venkatesan, M.B.B.S.[2]

Overview

Carcinoma of the penis is a malignant growth found on the skin or in the tissues of the penis. Carcinoma of the penis may be classified according to cell types into several subtypes: squamous cell carcinoma, adenocarcinoma, melanoma, basal cell carcinoma, lymphoma, and sarcoma. The incidence of carcinoma of the penis is approximately 1 per 100,000 men in the United States. On gross pathology, scaly patches or nodules, erythematous, and ulceration are characteristic findings of carcinoma of the penis. Common risk factors in the development of carcinoma of the penis are human papillomavirus, phimosis, poor genital hygiene, not being circumcised, weakened immune system, smoking, and treatment for psoriasis. And it is caused by an infection with human papillomavirus. The most common symptoms of carcinoma of the penis include non-healing lesion, change in the colour of the penis, redness or irritation of the penis, lump or thickening of the skin on the penis, phimosis, foul-smelling discharge or bleeding from the penis or from underneath the foreskin, itching or burning under the foreskin, swelling of the penis, lump in the groin, and dysuria. Biopsy is helpful in the diagnosis of carcinoma of the penis. The predominant therapy for carcinoma of the penis is surgical resection. Adjunctive chemotherapy, radiation therapy, and biological therapy may be required. Prognosis is generally good, and the 5-year survival rate of patients with carcinoma of the penis is approximately 67%.

Classification

Carcinoma of the penis may be classified according to cell types into several subtypes including, squamous cell carcinoma, adenocarcinoma, melanoma, basal cell carcinoma, lymphoma, sarcoma.

Pathophysiology

Most types of penile cancer traditionally begin as small lesions, most commonly on the glans or prepuce. About 95% of penile cancers develop from flat, scale-like cells called squamous cells. squamous cell carcinoma (SCC) can develop anywhere on the penis, but most develop on the foreskin (in uncircumcised men) or the glans. This type of cancer is typically slow growing. When found early, it is often curable. On gross pathology, the glans and the foreskin are the most common locations to find scaly patches, nodules, palpable painless lump, erythematous, ulceration, concurrent phimosis may conceal the lesion, surface of the lesion may be exophytic, flat, or ulcerated, chronic penile rash or subtle burning sensation and swollen inguinal lymph nodes as characteristic findings of carcinoma of penis. On microscopic histopathological analysis, keratinization and intercellular bridges are characteristic findings of carcinoma of the penis. Penile cancer arises from precursor lesions, which generally progress from low-grade to high-grade lesions.

Epidemiology and Demographics

The incidence of carcinoma of the penis is approximately 1 per 100,000 males in the United States. The majority of cases are reported in less developed areas. The incidence of penile cancer increases with age; the diagnostic median age usually is 40 - 70 years, median age 58 years. Penile cancer is rare if circumcision is done at birth, and is more common in cases of late circumcision (after age 10). Carcinoma of the penis is more prevalent in populations with lower education and higher poverty. More commonly seen in Hispanic and African American men; familial cases have occasionally been reported.

Risk Factors

Common risk factors in the development of carcinoma of the penis include human papillomavirus, phimosis, poor genital hygiene, uncircumcised males, weakened immune system, smoking, and psoralen ultraviolet A (PUVA) therapy treatment for psoriasis.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for carcinoma of the penis.

Causes

Carcinoma of the penis is caused by an infection with human papillomavirus.

Differential Diagnosis

Carcinoma of the penis must be differentiated from condyloma acuminata, penile intraepithelial neoplasia (PeIN), balanitis xerotica obliterans, Buschke-Lowenstein tumour, Bowenoid papulosis, leukoplakia.

Prognosis

Prognosis of carcinoma of the penis is generally good, and the 5-year survival rate is approximately 67%. The prognosis varies with the stage of tumor; stages 0–II have the most favorable prognosis.

Staging

Carcinoma of the penis may be classified into several subtypes based on TNM system and UICC staging system.

History and Symptoms

The most common symptoms of carcinoma of the penis include any non-healing lesion, change in the colour of the penis, redness, irritation of the penis, lump, thickening of the skin on the penis, phimosis, foul-smelling discharge, bleeding from the penis or from underneath the foreskin.

Physical Examination

Common physical examination findings of carcinoma of the penis include weight loss, pallor, inguinal lymphadenopathy, non-healing ulcer on the penis, mass on the penis, phimosis, skin induration on the penis, change in the colour of the penis, erythema of the penis, foul-smelling discharge, bleeding from the penis or from underneath the foreskin, as well as swelling of the penis.

Laboratory Tests

Some patients with carcinoma of the penis may have elevated concentration of serum calcium, which is usually suggestive of bone metastases.

X Ray

There are no X-ray findings associated with carcinoma of the penis. X-ray may be performed to detect metastases of penile cancer to lungs and bones.

CT

CT scan may be performed to detect metastases of carcinoma of the penis to surrounding lymph nodes, liver, lungs, and other organs.

MRI

MRI may be performed to detect metastases of carcinoma of the penis to brain, spinal cord, and nearby organs and tissues.

Ultrasound

Ultrasound may be helpful in the diagnosis of the extent of carcinoma of the penis.

Other Imaging Findings

There are no other imaging findings associated with carcinoma of the penis.

Other Diagnostic Studies

There are no other diagnostic study findings associated with carcinoma of the penis.

Biopsy

Biopsy is helpful in the diagnosis of carcinoma of the penis.

Medical Therapy

The predominant therapy for carcinoma of the penis is surgical resection. Adjunctive chemotherapy, radiation therapy, and biological therapy may be required.

Surgery

Surgery is the mainstay of treatment for carcinoma of the penis.

Primary Prevention

Effective measures for the primary prevention of carcinoma of the penis include circumcision, good personal hygiene, and safer sexual practices. Gardasil vaccine is recommended for men to prevent HPV infection.

Secondary Prevention

There are no secondary preventive measures available for carcinoma of the penis.

References


Template:WikiDoc Sources